Second Wave Of `Buckyball' Researchers Kicks Off Efforts

Two years ago, the 60-carbon, soccer ball-shaped buckminsterfullerene was just a curiosity for Larry Lewis, a staff chemist at the General Electric Co. Corporate Research & Development center in Schenectady, N.Y. At the time, his interest in the recently identified molecule was restricted to "what if" questions inspired by perusing numerous journal articles about it. He couldn't do any lab work with it, though, Lewis says, because "there wasn't enough of the stuff to do chemistry with." But al

Written byRicki Lewis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

But all of that changed last September, when scientists succeeded in making gram quantities of the material. Now, just about any bench scientist can join the original "buckyball" pioneers in exploring the properties of C60 in his or her own lab.

It was late on an August evening six years ago that Rice University professor Richard Smalley sat in his kitchen, cutting out shapes from a legal pad and taping them together. He was trying to come up with a model having 60 vertices to represent the 60-carbon molecule which he and his collaborators generated in the lab by laser-vaporizing carbon in helium gas. Chemist Harold Kroto was one of these collaborators. He had come to Rice from the University of Sussex in England to use the Houston school's laser technique, with which he hoped to be able to generate carbon chains he thought might be components of interstellar dust. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies